Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Amphiphilic conjugate nano-particle for treating tumors, as well as preparation method and application of same

A nanoparticle and amphiphilic technology, applied in the field of biomedicine, can solve problems such as difficult control and uneven size of drug carriers, and achieve the effect of reducing toxic and side effects

Active Publication Date: 2013-04-17
SHANGHAI JIAO TONG UNIV
View PDF3 Cites 34 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, the size of the drug carrier is often uneven and difficult to control

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amphiphilic conjugate nano-particle for treating tumors, as well as preparation method and application of same
  • Amphiphilic conjugate nano-particle for treating tumors, as well as preparation method and application of same
  • Amphiphilic conjugate nano-particle for treating tumors, as well as preparation method and application of same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Chlorambucil (408 mg), irinotecan (158 mg), N,N′-dicyclohexylcarbodiimide (DCC, 330 mg) and 4-dimethylaminopyridine (DMAP, 74 mg) Add it into the reaction bottle, then add 20 ml of chloroform, and stir at room temperature for 48 hours. Remove the precipitated insoluble matter dicyclohexyl urea (DCU) by filtration, use a mixture of dichloromethane and methanol (20:1) as eluent in the filtrate, and separate it by column chromatography to obtain phenylbutyrate nitrogen in the form of light yellow powder Mustard-irinotecan conjugates, yield 67%.

[0036] The chemical structure of the conjugate synthesized in this example is as follows: figure 1 shown. of the conjugates prepared in this example 1 H NMR and 13 C NMR spectrum as figure 2 and image 3 As shown, the test solvent is CDCl 3 , each absorption peak was assigned and marked in the spectrum. spectrum figure 2 The assignment of the proton peaks in is as follows: δ (ppm from TMS), 8.17-8.19 (1H, CHCHCCCHC), 7....

Embodiment 2

[0039] Chlorambucil (304 mg) was dissolved in 3 mL of thionyl chloride and reacted at 0°C for 3 hours. The thionyl chloride was removed by distillation under reduced pressure to give the chlorambucil chloride product (tan oil). Then the acid chloride product was dissolved in 5 ml of chloroform, slowly added dropwise to a solution of topotecan (630 mg) and triethylamine (144 μl) in 20 ml of chloroform, and reacted at room temperature for 24 hours. The precipitated white triethylamine hydrochloride was removed by filtration, and the filtrate used a mixture of dichloromethane and methanol (15:1) as the eluent, and was separated by column chromatography to obtain a light yellow powder chlorambucil-topology Tecan conjugate, yield 49%.

[0040] The chemical structure of the drug / drug conjugate synthesized in this example is as follows: Figure 5 shown.

[0041] The amphiphilic conjugate prepared above was dissolved in tetrahydrofuran, which was dropped into water at room temperat...

Embodiment 3

[0043] Add pintamustine (358 mg), irinotecan (158 mg), N,N′-dicyclohexylcarbodiimide (DCC, 309 mg) and 4-dimethylaminopyridine (DMAP, 74 mg) The reaction bottle was added with 20 ml of chloroform, and the reaction was stirred at room temperature for 48 hours. The precipitated insoluble dicyclohexyl urea (DCU) was removed by filtration, and the filtrate used a mixture of dichloromethane and methanol at a volume ratio of (20:1) as the eluent, and was separated by column chromatography to obtain a light yellow powder of Binda nitrogen mustard - Irinotecan conjugate, yield 64%.

[0044] The chemical structure of the conjugate synthesized in this example is as follows: Figure 6 shown.

[0045] The amphiphilic conjugate prepared above was dissolved in tetrahydrofuran, which was dropped into water at room temperature, and the tetrahydrofuran was removed to obtain an aqueous solution of nanoparticles of the amphiphilic conjugate. The average size of the anti-tumor nanoparticles pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Average sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of biological medicines, and particularly to an amphiphilic conjugate nano-particle for treating tumors, as well as a preparation method and application of the amphiphilic conjugate nano-particle. The nano-particle comprises an amphiphilic conjugate formed by esterification of a carboxyl containing hydrophobic anti-tumor medicine and a hydroxyl hydrophilic anti-tumor medicine. Compared with the prior art, self-assembly of the amphiphilic conjugate in water can be achieved to form the nano-particle, no medicine is required for conveying a carrier, the conjugate can achieve the medicine conveying, and the nano-particle can enter a tumor cell more effectively and reduce the toxic and side effects for normal cell through permeability enhancing and retention effects of a tumor tissue; and after the conjugate nano-particle enters the tumor cell, two types of antitumor medicines can be released through ester bond degradation, and the purpose of collaborative treatment of cancers by the two types of medicines can be achieved.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to an amphiphilic conjugate nanoparticle for treating tumors, a preparation method and an application thereof. Background technique [0002] Malignant neoplasms (cancers) have been the main diseases that lead to an increase in mortality in countries all over the world. Therefore, how to effectively treat malignant tumors has become one of the problems to be solved urgently in the world. At present, the treatment methods for malignant tumors mainly include the following types: surgical resection, chemotherapy, radiotherapy, immunotherapy and biological therapy. Among them, chemotherapy is one of the most effective treatments. However, most antineoplastic drugs have the following disadvantages, such as poor solubility, large toxic and side effects on normal tissues, and short blood residence time. In order to solve the above problems, a large number of documents have reported t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D491/22C07H19/09C07H1/00C07D519/00A61P35/00
Inventor 颜德岳黄平朱新远黄卫
Owner SHANGHAI JIAO TONG UNIV
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More